4,263 Shares in CME Group Inc. (NASDAQ:CME) Bought by Cipher Capital LP

09 Dec 2023, 13:52 by Tristan Rich · The Markets Daily

Cipher Capital LP acquired a new position in CME Group Inc. (NASDAQ:CME – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 4,263 shares of the financial services provider’s stock, valued at approximately $790,000.

Other institutional investors also recently modified their holdings of the company. Grayhawk Investment Strategies Inc. bought a new stake in shares of CME Group in the first quarter worth $28,000. Power Corp of Canada bought a new stake in shares of CME Group in the first quarter worth $26,000. Silicon Valley Capital Partners bought a new stake in shares of CME Group in the first quarter worth $27,000. Cascade Investment Advisors Inc. bought a new stake in shares of CME Group in the first quarter worth $27,000. Finally, MayTech Global Investments LLC bought a new stake in CME Group during the fourth quarter valued at $25,000. Institutional investors own 85.69% of the company’s stock.

Insider Buying and Selling

In related news, insider Derek Sammann sold 1,862 shares of the company’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $222.07, for a total value of $413,494.34. Following the sale, the insider now owns 9,694 shares in the company, valued at approximately $2,152,746.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other CME Group news, Director Dennis Suskind sold 1,500 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $213.60, for a total value of $320,400.00. Following the completion of the sale, the director now directly owns 3,167 shares of the company’s stock, valued at approximately $676,471.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Derek Sammann sold 1,862 shares of the company’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $222.07, for a total transaction of $413,494.34. Following the completion of the sale, the insider now directly owns 9,694 shares of the company’s stock, valued at $2,152,746.58. The disclosure for this sale can be found here. Insiders have sold 15,929 shares of company stock worth $3,494,509 in the last quarter. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ CME opened at $211.62 on Friday. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 1-year low of $166.54 and a 1-year high of $223.80. The firm has a market capitalization of $76.18 billion, a P/E ratio of 25.25, a P/E/G ratio of 2.39 and a beta of 0.43. The firm’s 50-day moving average price is $213.78 and its 200-day moving average price is $200.44.

CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 25th. The financial services provider reported $2.25 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.04. CME Group had a net margin of 57.03% and a return on equity of 11.70%. The company had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.34 billion. Equities research analysts anticipate that CME Group Inc. will post 9.14 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 28th. Investors of record on Friday, December 8th will be issued a $1.10 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $4.40 dividend on an annualized basis and a dividend yield of 2.08%. CME Group’s dividend payout ratio is presently 52.51%.

Analyst Ratings Changes

A number of brokerages have commented on CME. Rosenblatt Securities upped their price target on shares of CME Group from $173.00 to $180.00 and gave the company a “sell” rating in a research report on Thursday, October 26th. JPMorgan Chase & Co. upped their price target on shares of CME Group from $190.00 to $197.00 and gave the company a “neutral” rating in a research report on Wednesday, October 11th. Morgan Stanley upped their price target on shares of CME Group from $215.00 to $220.00 and gave the company an “equal weight” rating in a research report on Thursday, October 26th. Barclays cut their price target on shares of CME Group from $247.00 to $244.00 and set an “overweight” rating on the stock in a research report on Thursday, October 26th. Finally, Citigroup upped their price target on shares of CME Group from $215.00 to $240.00 and gave the company a “buy” rating in a research report on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $220.00.

Check Out Our Latest Stock Report on CME

CME Group Profile

(Free Report)